Conditions: Hepatitis C
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 32
Healthy volunteers: yes

Brief summary:
The main objective of this study is to investigate the influence of mild, moderate and severe renal impairment on the pharmacokinetics and safety of BI 201335 in comparison to a control group with normal renal function after single dose of BI 201335.

Detailed description:

Arms:
arm 1: Capsule for oral administration arm 2: Capsule for oral administration

Interventions: intervention 1: BI 201335 intervention 2: BI 201335
Intervention descriptions: intervention 1: Relevant treatment dose capsule (A) for oral administration intervention 2: Relevant treatment dose capsule (B) for oral administration

Protocol document: